|
|
Couldwell
WT, Surnock AA, Tobia AJ, Cabana BE, Stillerman CB, Forsyth PA, Appley AJ,
Spence AM, Hinton DR, Chen TC.
A phase 1/2 study of orally administered synthetic hypericin for treatment
of recurrent malignant gliomas.
Cancer. 2011 Mar 31;. [Epub ahead of print]
.JPG) Abstract |
.gif) Related articles
|
